SCHEMBL1366686

SCHEMBL1366686

O=C(c1cc2ccc(O)cc2oc1=O)c1cc2ccc(O)cc2oc1=O

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 4/20 0.77
ALDH1A1 P00352 3/20 0.77
HPGD P15428 2/20 0.77
MEN1 O00255 8/20 0.76
KMT2A Q03164 8/20 0.76
KDM4E B2RXH2 3/20 0.76
S1PR4 O95977 2/20 0.76
GLA P06280 2/20 0.76
GAA P10253 2/20 0.76
MAPT P10636 2/20 0.76
S1PR1 P21453 2/20 0.76
HTT P42858 1/20 0.70
NPSR1 Q6W5P4 1/20 0.69
RXFP1 Q9HBX9 1/20 0.69
PKM P14618 2/20 0.68
CTDSP1 Q9GZU7 1/20 0.66
PFKFB3 Q16875 1/20 0.64
LMNA P02545 1/20 0.63
HSD17B3 P37058 1/20 0.62
FLT3 P36888 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1368289 0.89 MEN1 (0.76) MIFALDH1A1HPGDMEN1KMT2A
SCHEMBL37883 0.88 MAOA (0.76) MIFALDH1A1HPGDMEN1KMT2A
SCHEMBL2471214 0.88 ALDH1A1 (1.00) MIFALDH1A1HPGDMEN1KMT2A
SCHEMBL11070463 0.86 MEN1 (0.71) MIFALDH1A1HPGDMEN1KMT2A
SCHEMBL893210 0.86 MEN1 (0.74) MIFALDH1A1HPGDMEN1KMT2A
SCHEMBL592707 0.86 MEN1 (1.00) MIFALDH1A1HPGDMEN1KMT2A
SCHEMBL8565684 0.86 MEN1 (0.69) MIFALDH1A1HPGDMEN1KMT2A
SCHEMBL1367700 0.86 MAOA (0.78) MIFALDH1A1HPGDMEN1KMT2A
SCHEMBL1368846 0.85 MIF (0.73) MIFALDH1A1HPGDMEN1KMT2A
SCHEMBL9238048 0.83 MIF (0.68) MIFALDH1A1HPGDMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8067461-B2 3-acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-11-29 US disclosed
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2009-11-05 US disclosed
WO-2006132947-A2 3-ACYL COUMARINS, THIOCHROMONES AND QUINOLONES AND THERAPEUTIC USES THEREOF TEMPLE UNIVERSITY- OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2006-12-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275650-A1 3-Acyl coumarins, thiochromones and quinolones and therapeutic uses thereof NQO2, NQO1, HCCS MIF 2517/4885ALDH1A1 617/4885HPGD 819/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.